West Pharmaceutical Services (WST) Net Margin (2016 - 2025)
Historic Net Margin for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to 15.93%.
- West Pharmaceutical Services' Net Margin fell 11800.0% to 15.93% in Q4 2025 from the same period last year, while for Dec 2025 it was 15.59%, marking a year-over-year decrease of 9300.0%. This contributed to the annual value of 15.59% for FY2025, which is 9300.0% down from last year.
- As of Q4 2025, West Pharmaceutical Services' Net Margin stood at 15.93%, which was down 11800.0% from 17.14% recorded in Q3 2025.
- In the past 5 years, West Pharmaceutical Services' Net Margin ranged from a high of 24.7% in Q2 2021 and a low of 12.38% during Q1 2025
- In the last 5 years, West Pharmaceutical Services' Net Margin had a median value of 17.98% in 2023 and averaged 18.72%.
- In the last 5 years, West Pharmaceutical Services' Net Margin surged by 99600bps in 2021 and then crashed by -70800bps in 2022.
- Quarter analysis of 5 years shows West Pharmaceutical Services' Net Margin stood at 20.21% in 2021, then plummeted by -30bps to 14.08% in 2022, then increased by 30bps to 18.27% in 2023, then dropped by -6bps to 17.11% in 2024, then dropped by -7bps to 15.93% in 2025.
- Its Net Margin stands at 15.93% for Q4 2025, versus 17.14% for Q3 2025 and 16.54% for Q2 2025.